Viyash Scientific Ltd has officially acquired 100% of BioForLife Italia S.r.l. through its Irish subsidiary, Alivira Animal Health Limited. The deal, valued at approximately EUR 16.97 million, includes a base payment of EUR 15 million and a deferred consideration of EUR 1.976 million. This move marks the formal integration of the Milan-based firm into Viyash Scientific’s global portfolio, strengthening the company's animal health division. Investors should look for updates on operational synergies and the final financial impact on consolidated results in upcoming quarters.
Viyash Scientific Completes Acquisition of BioForLife Italia
Base consideration of EUR 15.0 million paid; total deal valued at approximately EUR 16.97 million.
Acquisition executed via step-down subsidiary Alivira Animal Health Limited, Ireland.
Reader Takeaway: Strategic expansion into European animal health market; success depends on realizing operational synergies post-integration.
What just happened
Viyash Scientific Ltd has finalized the acquisition of 100% share capital of Milan-based BioForLife Italia S.r.l. (BFL Italy). The transaction, which follows months of planning disclosed in previous filings, was formally closed on October 1, 2026. The entity is now a step-down wholly owned subsidiary of the parent company.
Financial Structure
The acquisition cost is split into two components. A base consideration of EUR 15.0 million was paid upon closing, accounting for the agreed net financial position as of June 30, 2026. A deferred payment of EUR 1.976 million remains, subject to final adjustments based on the net financial position as of the closing date, October 1, 2026.
Governance and Management
To ensure seamless integration, representatives from Alivira Animal Health Limited have been appointed to the Board of BFL Italy. This management structure facilitates direct oversight from the parent company and aligns the Italian entity’s operations with existing group standards.
What to track next
Shareholders should monitor upcoming quarterly disclosures for details on the finalized net financial position adjustments and the integration of BFL Italy’s revenues into the company's consolidated financial statements. Management is expected to provide insights on how this European presence will drive future growth.